No matches

Rhinology

ADVENT at IRS-ISIAN | Evolving Perspectives in CRSwNP: From Symptom Control to Disease Remission

Join Profs. Shigeharu Fujieda, Peter Hellings, and Eugenio De Corso for an educational symposium on the evolving understanding of disease control and clinical remission in CRSwNP.

MD, PhD

Peter Hellings +2 more

Past event

5April2024

Location

Tokyo Japan

Learning objectives

Identify hallmarks of disease control in CRSwNP
Set appropriate goals beyond symptom control for patients with CRSwNP
Evaluate recently published definitions of remission in CRSwNP with an eye toward improving patient outcomes

Description

Join Professors Shigeharu Fujieda, MD, PhD, Peter Hellings, MD, PhD, and Eugenio De Corso, MD, PhD, as they consider the evolving understanding of disease control and clinical remission in CRSwNP. The panel will discuss hallmarks of disease control, recent consensus publications defining what remission means for patients with CRSwNP, and real-world perspectives on the potential for achieving remission with available biologic therapies.

Agenda

Welcome and Introductions

Shigeharu Fujieda (Chair)

Guideline Definitions of Control in CRSwNP

Peter Hellings

Emerging Expert Definitions of Remission in CRSwNP

Peter Hellings
Eugenio De Corso

Remission in CRSwNP: A Real-World Perspective

Eugenio De Corso

Panel Discussion: From Concept to Clinic: The Benefits of Pursuing Remission and the Key Components for Providers and Patients

All Faculty

Discussion/Q&A

All Faculty

This event is co-sponsored between ISIAN & IRS 2024 and Sanofi and Regeneron. The speakers are being compensated and/or receiving honoraria from Sanofi and Regeneron in connection with this program.

Location

Tokyo Japan

Speakers

Rhinology

MD, PhD

Peter Hellings

Professor and Clinic Head of the Department of Otorhinolaryngology | University Hospitals of Leuven, Belgium

Rhinology

MD, PhD

Eugenio De Corso

Adjunct Professor of Otorhinolaryngology | Catholic University of the Sacred Heart, Milan, Italy

Allergy/Immunology

MD, PhD

Shigeharu Fujieda

Professor in the Division of Otorhinolargngology, Head & Neck Surgery | University of Fukui, Matsuoka, Japan

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region

Rhinology

ADVENT at IRS-ISIAN | Evolving Perspectives in CRSwNP: From Symptom Control to Disease Remission

Join Profs. Shigeharu Fujieda, Peter Hellings, and Eugenio De Corso for an educational symposium on the evolving understanding of disease control and clinical remission in CRSwNP.

MD, PhD

Peter Hellings +2 more

Past event

5April2024

Location

Tokyo Japan

Learning objectives

Identify hallmarks of disease control in CRSwNP
Set appropriate goals beyond symptom control for patients with CRSwNP
Evaluate recently published definitions of remission in CRSwNP with an eye toward improving patient outcomes

Description

Agenda

Welcome and Introductions

Shigeharu Fujieda (Chair)

Guideline Definitions of Control in CRSwNP

Peter Hellings

Emerging Expert Definitions of Remission in CRSwNP

Peter Hellings
Eugenio De Corso

Remission in CRSwNP: A Real-World Perspective

Eugenio De Corso

Panel Discussion: From Concept to Clinic: The Benefits of Pursuing Remission and the Key Components for Providers and Patients

All Faculty

Discussion/Q&A

All Faculty

This event is co-sponsored between ISIAN & IRS 2024 and Sanofi and Regeneron. The speakers are being compensated and/or receiving honoraria from Sanofi and Regeneron in connection with this program.

Location

Tokyo Japan

Speakers

Rhinology

MD, PhD

Peter Hellings

Professor and Clinic Head of the Department of Otorhinolaryngology | University Hospitals of Leuven, Belgium

Rhinology

MD, PhD

Eugenio De Corso

Adjunct Professor of Otorhinolaryngology | Catholic University of the Sacred Heart, Milan, Italy

Allergy/Immunology

MD, PhD

Shigeharu Fujieda

Professor in the Division of Otorhinolargngology, Head & Neck Surgery | University of Fukui, Matsuoka, Japan